Gemini Therapeutics Inc (GMTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMTX | PRPH | MURA | ||
| Company | Gemini Therapeutics Inc | Prophase Labs Inc | Mural Oncology Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.6000 | 3.13 | 3.44 | ||
| High | 14.1000 | 3.15 | 3.44 | ||
| Low | 13.5000 | 3.07 | 3.32 | ||
| Last | 13.5000 | 3.07 | 3.32 | ||
| Change | unch | -0.05 | -0.11 | ||
| % Change | unch | -1.60% | -3.21% | ||
| Volume | 6,380 | 3,043 | 20,976 | ||
| 20-Day Average Volume | 176,225 | 30,942 | 320,199 | ||
| Previous Close | 13.5000 | 3.12 | 3.43 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5780 | 3.62 | 3.19 | ||
| 20-Day Raw Stochastic | 30.91% | 2.87% | 74.44% | ||
| 20-Day Relative Strength | 33.17% | 29.13% | 49.97% | ||
| Weighted Alpha | -39.50 | -56.73 | -39.10 | ||
| Today's Opinion | 24% Sell | 88% Sell | N/A | ||
| Previous Opinion | 24% Sell | 88% Sell | N/A | ||
| Last Month's Opinion | 96% Buy | 56% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.34% since 12/21/22 | -2.48% since 07/15/24 | +1.18% since 07/15/24 | ||
| Low | 1.1800 on 12/28/22 | 3.10 on 07/19/24 | 3.28 on 07/16/24 | ||
| High | 1.7100 on 12/27/22 | 3.43 on 07/17/24 | 3.51 on 07/18/24 | ||
| 1-Month | |||||
| %Chg | -21.97% since 11/29/22 | -28.47% since 06/21/24 | +3.36% since 06/21/24 | ||
| Low | 1.1800 on 12/28/22 | 3.10 on 07/19/24 | 2.88 on 07/05/24 | ||
| High | 1.7300 on 12/05/22 | 4.49 on 06/24/24 | 3.51 on 07/18/24 | ||
| 3-Month | |||||
| %Chg | -11.18% since 09/29/22 | -35.92% since 04/22/24 | -6.71% since 04/22/24 | ||
| Low | 1.1800 on 12/28/22 | 3.10 on 07/19/24 | 2.88 on 07/05/24 | ||
| High | 2.1000 on 10/26/22 | 5.62 on 05/06/24 | 4.18 on 05/15/24 | ||
| 6-Month | |||||
| %Chg | -21.97% since 06/29/22 | -38.55% since 01/22/24 | -23.71% since 01/22/24 | ||
| Low | 1.1800 on 12/28/22 | 3.10 on 07/19/24 | 2.88 on 07/05/24 | ||
| High | 2.1200 on 08/11/22 | 7.48 on 04/16/24 | 5.62 on 03/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 58,493 | 59,526 | 58,049 | ||
| Shares Outstanding, K | 43,328 | 19,079 | 16,924 | ||
| Annual Sales | 0 | 44,380,000 | 0 | ||
| Annual Net Income | -71,870,000 | -16,780,000 | -207,450,000 | ||
| Last Quarter Sales | 0 | 3,630,000 | 0 | ||
| Last Quarter Net Income | -3,280,000 | -6,270,000 | -30,920,000 | ||
| 60-Month Beta | -0.12 | -0.10 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 11/10/22 | -0.07 on 05/09/24 | -1.84 on 05/14/24 | ||
| Latest Earnings Date | 11/21/22 | 08/08/24 | 08/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||